Advancements in high-intensity focused ultrasound for urological tumor research and application

High-intensity focused ultrasound (HIFU), a non-invasive therapeutic approach, has made significant inroads in urological oncology, notably for kidney, bladder, and prostate cancers. Its advantages in treating prostate cancer are particularly pronounced, offering less invasive treatment with faster recovery and superior organ function preservation compared to traditional methods. HIFU is an advantageous option for patients with localized prostate cancer who prefer nonsurgical treatments or have a high demand for quality of life. Despite its benefits, HIFU faces limitations requiring further research and clinical validation to ensure safety and effectiveness. This paper provides a concise review of HIFU's current application in urological tumor treatment, highlighting its role in prostate cancer therapy and exploring its potential in the adjuvant treatment of advanced prostate cancer, offering insights for its future role in urological oncology.